Die Frühgeborenenretinopathie

 

 Buy Article Permissions and Reprints

Zusammenfassung

Dieser Übersichtsartikel fasst den aktuellen Stand des Wissens über die Frühgeborenenretinopathie (Retinopathia praematurorum, RPM) zusammen. Kenntnisse über dieses meist bei extrem unreifen Säuglingen auftretende Krankheitsbild sind weiterhin wichtig, da trotz verbesserter neonatologischer Intensivmedizin die RPM auch in Zukunft auftritt, aber durch augenärztliche Screeninguntersuchungen und ggf. durch eine Therapie zum optimalen Zeitpunkt das Erblindungsrisiko deutlich reduziert werden kann. Es werden die historische Entwicklung der RPM kurz dargestellt sowie die neuesten Erkenntnisse der Pathophysiologie beschrieben. Die Ergebnisse der großen multizentrischen Therapiestudien werden zusammengefasst. Die aktuelle deutsche Leitlinie zur Screeninguntersuchung wird erläutert und mit den Empfehlungen anderer Länder verglichen. Die verschiedenen Therapiemöglichkeiten und Behandlungsergebnisse werden diskutiert, derzeit ist die indirekte Laserkoagulation im therapiebedürftigen Stadium die Therapie der Wahl. Die ophthalmologischen Spätveränderungen bei ehemaligen Frühgeborenen werden erwähnt. Am Ende folgt ein Ausblick auf mögliche zukünftige Behandlungsmethoden wie z. B. der Einsatz von antiangiogenen Faktoren.

Abstract

This review summarizes the knowledge and highlights recent advances in clinical research of retinopathy of prematurity (ROP). This disease is still important, because improvements in neonatal intensive care during the last years have increased the survival of the most immature newborns, but did not diminish the ROP frequency. Ophthalmologic screening and, if applicable, laser treatment at the optimal time for advanced ROP prevents blindness in most cases. The history, classification and the modern concepts of ROP pathophysiology are described. The results of various multicenter treatment trials are summarized. The current German screening guidelines are discussed with the guidelines of other nations. The therapeutic treatment strategies and the treatment results are discussed. The ophthalmologic disorders of former preterm infants, as higher rates of amblyopia, strabismus, and refractive error, are mentioned. Possible future therapies, e. g. anti-angiogenic factors are discussed.

Literatur

• 1 The Committee for the Classification of Retinopathy of Prematurity . An international classification of retinopathy of prematurity.  Arch Ophthalmol. 1984;  102 1130-1134
  CrossrefPubMedGoogle Scholar
• 2 Committee on Fetus and Newborn . Vitamin E and the prevention of retinopathy of prematurity.  Pediatrics. 1985;  76 315-316
  PubMedGoogle Scholar
• 3 The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity . An international classification of retinopathy of prematurity. II. The classification of retinal detachment.  Arch Ophthalmol. 1987;  105 906-912
  CrossrefPubMedGoogle Scholar
• 4 Cryotherapy for Retinopathy of Prematurity Cooperative Group . Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results.  Arch Ophthalmol. 1988;  106 471-479
  CrossrefPubMedGoogle Scholar
• 5 Cryotherapy for Retinopathy of Prematurity Cooperative Group . Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome.  Arch Ophthalmol. 1990;  108 195-204
  PubMedGoogle Scholar
• 6 Cryotherapy for Retinopathy of Prematurity Cooperative Group . The natural ocular outcome of premature birth and retinopathy. Status at 1 year.  Arch Ophthalmol. 1994;  112 903-912
  PubMedGoogle Scholar
• 7 Canadian Association of Pediatric Ophthalmologists Ad Hoc Committee on Standards of Screening Examination for Retinopathy of Prematurity . Guidelines for screening examinations for retinopathy of prematurity.  Can J Ophthalmol. 2000;  35 251-252; discussion 3 - 4
  PubMedGoogle Scholar
• 8 Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years.  Arch Ophthalmol. 2001;  119 1110-1118
  CrossrefPubMedGoogle Scholar
• 9 Contrast sensitivity at age 10 years in children who had threshold retinopathy of prematurity.  Arch Ophthalmol. 2001;  119 1129-1133
  PubMedGoogle Scholar
• 10 Effect of retinal ablative therapy for threshold retinopathy of prematurity: results of Goldmann perimetry at the age of 10 years.  Arch Ophthalmol. 2001;  119 1120-1125
  PubMedGoogle Scholar
• 11 Screening examination of premature infants for retinopathy of prematurity.  Pediatrics. 2001;  108 809-811
  CrossrefPubMedGoogle Scholar
• 12 Agostini H T, Hansen L L. Angioproliferative Netzhauterkrankungen bei Ischämie.  Ophthalmologe. 2003;  100 371-377
  CrossrefPubMedGoogle Scholar
• 13 Arnold R W, Kesler K, Avila E. Susceptibility to retinopathy of prematurity in Alaskan Natives.  J Pediatr Ophthalmol Strabismus. 1994;  31 192-194
  PubMedGoogle Scholar
• 14 Sira I Ben, Nissenkorn I, Kremer I. Retinopathy of prematurity.  Surv Ophthalmol. 1988;  33 1-16
  PubMedGoogle Scholar
• 15 Blodi F C. Symposium: Retrolental fibroplasia (retinopathy of prematurity). Management.  Trans Am Acad Ophthalmol Otolaryngol. 1995;  59 35
  PubMedGoogle Scholar
• 16 Bolton D P, Cross K W. Further observations on cost of preventing retrolental fibroplasia.  Lancet. 1974;  1 (7855) 445-448
  PubMedGoogle Scholar
• 17 Bossi E, Koerner F. Retinopathy of prematurity.  Intensive Care Med. 1995;  21 241-246
  CrossrefPubMedGoogle Scholar
• 18 Brennan R, Gnanaraj L, Cottrell D G. Retinopathy of prematurity in practice. I: Screening for threshold disease.  Eye. 2003;  17 183-188
  CrossrefPubMedGoogle Scholar
• 19 Brooks S E, Johnson M, Wallace D K. et al . Treatment outcome in fellow eyes after laser photocoagulation for retinopathy of prematurity.  Am J Ophthalmol. 1999;  127 56-61
  CrossrefPubMedGoogle Scholar
• 20 Bullard S R, Donahue S P, Feman S S. et al . The decreasing incidence and severity of retinopathy of prematurity.  J Aapos. 1999;  3 46-52
  PubMedGoogle Scholar
• 21 Burgess P, Johnson A. Ocular defects in infants of extremely low birth weight and low gestational age.  Br J Ophthalmol. 1991;  75 84-87
  PubMedGoogle Scholar
• 22 Caflisch S R, Bucher H U, Santo B. et al . Ophthalmologische Störungen ehemals extrem kleiner Frühgeborener im Alter von 10 Jahren.  Monatsschr Kinderheilkd. 1998;  146 230-234
  CrossrefPubMedGoogle Scholar
• 23 Capone A Jr, Trese M T. Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments.  Ophthalmology. 2001;  108 2068-2070
  CrossrefPubMedGoogle Scholar
• 24 Carrasquillo K G, Ricker J A, Rigas I K. et al . Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.  Invest Ophthalmol Vis Sci. 2003;  44 290-299
  CrossrefPubMedGoogle Scholar
• 25 Cats B P, Tan K E. Prematures with and without regressed retinopathy of prematurity: comparison of long-term (6 - 10 years) ophthalmological morbidity.  J Pediatr Ophthalmol Strabismus. 1989;  26 271-275
  PubMedGoogle Scholar
• 26 Charles S. Vitreoretinal surgery for retinopathy of prematurity.  Birth Defects Orig Artic Ser. 1988;  24 287-293
  PubMedGoogle Scholar
• 27 Clark D I, Laws F, Wood I CJ. et al . Axial growth of the eye and refractive error following retinopathy of prematurity (ROP) - a longitudinal study.  Invest Ophthalmol Vis Sci. 1996;  37 370
  PubMedGoogle Scholar
• 28 Clemens S, Eckardt C, Gerding H. et al . Leitlinie zur augenärztlichen Screening-Untersuchung von Frühgeborenen.  Ophthalmologe. 1999;  96 257-263
  Google Scholar
• 29 Cunningham S, Fleck B W, Elton R A. et al . Transcutaneous oxygen levels in retinopathy of prematurity.  Lancet. 1995;  346 (8988) 1464-1465
  CrossrefPubMedGoogle Scholar
• 30 Dobson V, Quinn G E, Summers C G. et al . Effect of acute-phase retinopathy of prematurity on grating acuity development in the very low birth weight infant. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.  Invest Ophthalmol Vis Sci. 1994;  35 4236-4244
  PubMedGoogle Scholar
• 31 Dogru M, Shirabe H, Nakamura M. et al . Development of grating acuity in infants with Retinopathy of Prematurity.  Acta Ophthalmol Scand. 1999;  77 72-75
  CrossrefPubMedGoogle Scholar
• 32 Fielder A R, Levene M I. Screening for retinopathy of prematurity.  Arch Dis Child. 1992;  67 860-867
  PubMedGoogle Scholar
• 33 Fielder A R, Shaw D E, Robinson J. et al . Natural history of retinopathy of prematurity: a prospective study.  Eye. 1992;  6 233-242
  CrossrefPubMedGoogle Scholar
• 34 Fledelius H C. Prematurity and the eye.  Acta Ophthalmol. 1976;  54: Suppl. 128
  PubMedGoogle Scholar
• 35 Fledelius H C. Retinopathy of prematurity in Denmark. Epidemiological considerations and screening limits.  Eur J Ophthalmol. 1996;  6 183-186
  PubMedGoogle Scholar
• 36 Fledelius H C. Pre-term delivery and subsequent ocular development. A 7 - 10 year follow-up of children screened 1982 - 84 for ROP. 3) Refraction. Myopia of prematurity.  Acta Ophthalmol Scand. 1996;  74 297-300
  PubMedGoogle Scholar
• 37 Fledelius H C. Pre-term delivery and subsequent ocular development. A 7 - 10 year follow-up of children screened 1982 - 84 for ROP. 4) Oculometric - and other metric considerations.  Acta Ophthalmol Scand. 1996;  74 301-305
  PubMedGoogle Scholar
• 38 Fledelius H C. Pre-term delivery and subsequent ocular development. A 7 - 10 year follow-up of children screened 1982 - 84 for ROP. 1) Visual function, slit-lamp findings, and fundus appearance.  Acta Ophthalmol Scand. 1996;  74 288-293
  PubMedGoogle Scholar
• 39 Fledelius H C, Dahl H. Retinopathy of prematurity, a decrease in frequency and severity. Trends over 16 years in a Danish county.  Acta Ophthalmol Scand. 2000;  78 359-361
  CrossrefPubMedGoogle Scholar
• 40 Flynn J T, Bancalari E, Bachynski B N. et al . Retinopathy of prematurity. Diagnosis, severity, and natural history.  Ophthalmology. 1987;  94 620-629
  PubMedGoogle Scholar
• 41 Flynn J T. The premature retina: a model for the in vivo study of molecular genetics?.  Eye. 1992;  6 161-165
  PubMedGoogle Scholar
• 42 Foroozan R, Connolly B P, Tasman W S. Outcomes after laser therapy for threshold retinopathy of prematurity.  Ophthalmology. 2001;  108 1644-1646
  CrossrefPubMedGoogle Scholar
• 43 Gallo J E, Lennerstrand G. A population-based study of ocular abnormalities in premature children aged 5 to 10 years.  Am J Ophthalmol. 1991;  111 539-547
  PubMedGoogle Scholar
• 44 Gaynon M W, Stevenson D K, Sunshine P. et al . Supplemental oxygen may decrease progression of prethreshold disease to threshold retinopathy of prematurity.  J Perinatol. 1997;  17 434-438
  PubMedGoogle Scholar
• 45 Gibson D L, Sheps S B, Uh S H. et al . Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic.  Pediatrics. 1990;  86 405-412
  PubMedGoogle Scholar
• 46 Gilbert C, Rahi J, Eckstein M. et al . Retinopathy of prematurity in middle-income countries.  Lancet. 1997;  350 (9070) 12-14
  CrossrefPubMedGoogle Scholar
• 47 Goggin M, O’Keefe M. Diode laser for retinopathy of prematurity - early outcome.  Br J Ophthalmol. 1993;  77 559-562
  PubMedGoogle Scholar
• 48 Gordon R A, Donzis P B. Myopia associated with retinopathy of prematurity.  Ophthalmology. 1986;  93 1593-1598
  PubMedGoogle Scholar
• 49 Greven C, Tasman W. Scleral buckling in stages 4B and 5 retinopathy of prematurity.  Ophthalmology. 1990;  97 817-820
  PubMedGoogle Scholar
• 50 Hartnett M E. Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity.  Retina. 2003;  23 322-329
  CrossrefPubMedGoogle Scholar
• 51 Hatfield E M. Blindness in infants and young children.  Sight Sav Rev. 1972;  42 69-89
  PubMedGoogle Scholar
• 52 Hellstrom A, Perruzzi C, Ju M. et al . Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity.  Proc Natl Acad Sci USA. 2001;  98 5804-5808
  CrossrefPubMedGoogle Scholar
• 53 Hindle N W. Cryotherapy for retinopathy of prematurity: timing of intervention.  Br J Ophthalmol. 1986;  70 269-276
  PubMedGoogle Scholar
• 54 Hiraoka M, Berinstein D M, Trese M T. et al . Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity.  J Hum Genet. 2001;  46 178-181
  CrossrefPubMedGoogle Scholar
• 55 Hirose T, Schepens C L. Open sky vitrectomy in stage 5 ROP-anatomical and visual results. Presented at the annual meeting of the American Academy of Ophthalmology. New Orleans 1989
  Google Scholar
• 56 Hittner H M, Rhodes L M, McPherson A R. Anterior segment abnormalities in cicatricial retinopathy of prematurity.  Ophthalmology. 1979;  86 803-816
  PubMedGoogle Scholar
• 57 Holmstrom G, el A zazi M, Jacobson L. et al . A population based, prospective study of the development of ROP in prematurely born children in the Stockholm area of Sweden.  Br J Ophthalmol. 1993;  77 417-423
  PubMedGoogle Scholar
• 58 Holmstrom G, el A zazi M, Kugelberg U. Ophthalmological follow up of preterm infants: a population based, prospective study of visual acuity and strabismus.  Br J Ophthalmol. 1999;  83 143-150
  CrossrefPubMedGoogle Scholar
• 59 Horbar J D, McAuliffe T L, Adler S M. et al . Variability in 28-day outcomes for very low birth weight infants: an analysis of 11 neonatal intensive care units.  Pediatrics. 1988;  82 554-559
  PubMedGoogle Scholar
• 60 Hughes S, Yang H, Chan-Ling T. Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis.  Invest Ophthalmol Vis Sci. 2000;  41 1217-1228
  PubMedGoogle Scholar
• 61 Isenberg S J. Macular development in the premature infant.  Am J Ophthalmol. 1986;  101 74-80
  PubMedGoogle Scholar
• 62 Jandeck C, Kellner U, Helbig H. et al . Natural course of retinal development in preterm infants without threshold retinopathy.  Ger J Ophthalmol. 1995;  4 131-136
  PubMedGoogle Scholar
• 63 Jandeck C. Refraktionsfehler bei Frühgeborenen mit und ohne Koagulationsbehandlung.  Orthoptik-Pleoptik. 1999;  23 25-32
  PubMedGoogle Scholar
• 64 Jandeck C, Kellner U, Foerster M H. Späte retinale Komplikationen bei Frühgeborenen mit regressiven Veränderungen.  Klin Monatsbl Augenheilkd. 2004;  221 96-100
  Article in Thieme ConnectPubMedGoogle Scholar
• 65 Keith C G. Visual outcome and effect of treatment in stage III developing retrolental fibroplasia.  Br J Ophthalmol. 1982;  66 446-449
  PubMedGoogle Scholar
• 66 Kellner U, Jandeck C, Helbig H. et al . Überprüfung publizierter Empfehlungen für Screening-Untersuchungen bei Retinopathia praematurorum.  Ophthalmologe. 1995;  92 681-684
  PubMedGoogle Scholar
• 67 Kinsey V E. Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen.  Ama Arch Opthalmol. 1956;  56 481-543
  PubMedGoogle Scholar
• 68 Kinsey V E, Arnold H J, Kalina R E. et al . PaO2 levels and retrolental fibroplasia: a report of the cooperative study.  Pediatrics. 1977;  60 655-668
  PubMedGoogle Scholar
• 69 Krumpaszky H G, Klauss V. [Cause of blindness in Bavaria. Evaluation of a representative sample from blindness compensation records of Upper Bavaria].  Klin Monatsbl Augenheilkd. 1992;  200 142-146
  PubMedGoogle Scholar
• 70 Krzystolik M G, Afshari M A, Adamis A P. et al . Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.  Arch Ophthalmol. 2002;  120 338-346
  PubMedGoogle Scholar
• 71 Kumar H, Nainiwal S, Singha U. et al . Stress induced by screening for retinopathy of prematurity.  J Pediatr Ophthalmol Strabismus. 2002;  39 349-350
  PubMedGoogle Scholar
• 72 Kushner B J, Essner D, Cohen I J. et al . Retrolental fibroplasia. II. Pathologic correlation.  Arch Ophthalmol. 1977;  95 29-38
  PubMedGoogle Scholar
• 73 Lanman J T, Guy L P, Dancis J. Retrolental fibroplasia and oxygen therapy.  J Am Med Assoc. 1954;  155 223-226
  PubMedGoogle Scholar
• 74 Larsson E, Carle-Petrelius B, Cernerud G. et al . Incidence of ROP in two consecutive Swedish population based studies.  Br J Ophthalmol. 2002;  86 1122-1126
  CrossrefPubMedGoogle Scholar
• 75 Laws D E, Haslett R, Ashby D. et al . Axial length biometry in infants with retinopathy of prematurity.  Eye. 1994;  8 (Pt 4) 427-430
  PubMedGoogle Scholar
• 76 Laws F, Laws D, Clark D. Cryotherapy and laser treatment for acute retinopathy of prematurity: refractive outcomes, a longitudinal study.  Br J Ophthalmol. 1997;  81 12-15
  PubMedGoogle Scholar
• 77 Lemons J A, Bauer C R, Oh W. et al . Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network.  Pediatrics. 2001;  107 E1
  CrossrefPubMedGoogle Scholar
• 78 Machemer R. Late traction detachment in retinopathy of prematurity or ROP-like cases.  Graefes Arch Clin Exp Ophthalmol. 1993;  231 389-394
  CrossrefPubMedGoogle Scholar
• 79 McDonald A D. Cerebral palsy in children of very low birth weight.  Arch Dis Child. 1963;  38 579-588
  PubMedGoogle Scholar
• 80 McNamara J A, Tasman W, Brown G C. et al . Laser photocoagulation for stage 3 + retinopathy of prematurity.  Ophthalmology. 1991;  98 576-580
  PubMedGoogle Scholar
• 81 Nagata M, Takishima R. [One side of the coin of functions of public health nursing with the establishment of home care helpers].  Kango. 1968;  20 130-134
  PubMedGoogle Scholar
• 82 Ng E Y, Connolly B P, McNamara J A. et al . A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome.  Ophthalmology. 2002;  109 928-934; discussion 35
  CrossrefPubMedGoogle Scholar
• 83 NIH News Release. Oxygen restriction can be eased for premature infants with blinding eye disease Press release 2000
  Google Scholar
• 84 Nissenkorn I, Yassur Y, Mashkowski D. et al . Myopia in premature babies with and without retinopathy of prematurity.  Br J Ophthalmol. 1983;  67 170-173
  PubMedGoogle Scholar
• 85 Nissenkorn I, Kremer I, Gilad E. et al . ‘Rush’ type retinopathy of prematurity: report of three cases.  Br J Ophthalmol. 1987;  71 559-562
  PubMedGoogle Scholar
• 86 Onofrey C B, Feuer W J, Flynn J T. The outcome of retinopathy of prematurity: screening for retinopathy of prematurity using an outcome predictive program.  Ophthalmology. 2001;  108 27-34; discussion 5
  CrossrefPubMedGoogle Scholar
• 87 Page J M, Schneeweiss S, Whyte H E. et al . Ocular sequelae in premature infants.  Pediatrics. 1993;  92 787-790
  PubMedGoogle Scholar
• 88 Palmer E A, Flynn J T, Hardy R J. et al . Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.  Ophthalmology. 1991;  98 1628-1640
  Google Scholar
• 89 Paysse E A, Lindsey J L, Coats D K. et al . Therapeutic outcomes of cryotherapy versus transpupillary diode laser photocoagulation for threshold retinopathy of prematurity.  J Aapos. 1999;  3 234-240
  PubMedGoogle Scholar
• 90 Pearce I A, Pennie F C, Gannon L M. et al . Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser.  Br J Ophthalmol. 1998;  82 1254-1259
  PubMedGoogle Scholar
• 91 Penn J S, Tolman B L, Lowery L A. Variable oxygen exposure causes preretinal neovascularization in the newborn rat.  Invest Ophthalmol Vis Sci. 1993;  34 576-585
  PubMedGoogle Scholar
• 92 Pennefather P M, Clarke M P, Strong N P. et al . Ocular outcome in children born before 32 weeks gestation.  Eye. 1995;  9 (Pt 6 Supp) 26-30
  PubMedGoogle Scholar
• 93 Pennefather P M, Tin W, Strong N P. et al . Refractive errors in children born before 32 weeks gestation.  Eye. 1997;  11 (Pt 5) 736-743
  PubMedGoogle Scholar
• 94 Phelps D L. Retinopathy of prematurity: an estimate of vision loss in the United States - 1979.  Pediatrics. 1981;  67 924-925
  PubMedGoogle Scholar
• 95 Pierce E A, Foley E D, Smith L E. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.  Arch Ophthalmol. 1996;  114 1219-1228
  CrossrefPubMedGoogle Scholar
• 96 Plate K H, Breier G, Weich H A. et al . Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.  Nature. 1992;  359 845-848
  CrossrefPubMedGoogle Scholar
• 97 Pohlandt F. Frühgeburt an der Grenze zur Lebensfähigkeit des Kindes.  Z Geburtshilfe Neonatol. 1998;  202 261-263
  PubMedGoogle Scholar
• 98 Pollard Z F. Lensectomy for secondary angle-closure glaucoma in advanced cicatricial retrolental fibroplasia.  Ophthalmology. 1984;  91 395-398
  PubMedGoogle Scholar
• 99 Quinn G E, Johnson L, Abbasi S. Onset of retinopathy of prematurity as related to postnatal and postconceptional age.  Br J Ophthalmol. 1992;  76 284-288
  PubMedGoogle Scholar
• 100 Quinn G E, Dobson V, Repka M X. et al . Development of myopia in infants with birth weights less than 1251 grams. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.  Ophthalmology. 1992;  99 329-340
  CrossrefPubMedGoogle Scholar
• 101 Quinn G E, Dobson V, Biglan A. et al . Correlation of retinopathy of prematurity in fellow eyes in the cryotherapy for retinopathy of prematurity study. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.  Arch Ophthalmol. 1995;  113 469-473
  PubMedGoogle Scholar
• 102 Raju T N, Langenberg P, Bhutani V. et al . Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials.  J Pediatr. 1997;  131 844-850
  PubMedGoogle Scholar
• 103 Rettwitz-Volk W. [Mortality and morbidity of preterm infants - a synopsis of the german neonatal census 2001].  Z Geburtshilfe Neonatol. 2003;  207 143-147
  Article in Thieme ConnectPubMedGoogle Scholar
• 104 Reynolds J D, Hardy R J, Kennedy K A. et al . Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group.  N Engl J Med. 1998;  338 1572-1576
  CrossrefPubMedGoogle Scholar
• 105 Riise R. Nordic registers of visually impaired children.  Scand J Soc Med. 1993;  21 66-68
  PubMedGoogle Scholar
• 106 Robinson R, O’Keefe M. Follow-up study on premature infants with and without retinopathy of prematurity.  Br J Ophthalmol. 1993;  77 91-94
  PubMedGoogle Scholar
• 107 Saunders R A, Donahue M L, Christmann L M. et al . Racial variation in retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.  Arch Ophthalmol. 1997;  115 604-608
  CrossrefPubMedGoogle Scholar
• 108 Schalij-Delfos N E, Zijlmans B L, Wittebol-Post D. et al . Screening for retinopathy of prematurity: do former guidelines still apply?.  J Pediatr Ophthalmol Strabismus. 1996;  33 35-38
  PubMedGoogle Scholar
• 109 Schalij-Delfos N E, Cats B P. Retinopathy of prematurity: the continuing threat to vision in preterm infants. Dutch survey from 1986 to 1994.  Acta Ophthalmol Scand. 1997;  75 72-75
  PubMedGoogle Scholar
• 110 Seiberth V, Linderkamp O, Akkoyun-Vardarli I. et al . Oxygen therapy in acute retinopathy of prematurity stage 3.  Invest Ophthalmol Vis Sci. 1998;  39 S820
  PubMedGoogle Scholar
• 111 Seiberth V, Linderkamp O. Risk factors in retinopathy of prematurity. a multivariate statistical analysis.  Ophthalmologica. 2000;  214 131-135
  CrossrefPubMedGoogle Scholar
• 112 Seiberth V, Woldt C. Weitwinkelfundusdokumentation bei Retinopathia praematurorum.  Ophthalmologe. 2001;  98 960-963
  CrossrefPubMedGoogle Scholar
• 113 Snir M, Nissenkorn I, Sherf I. et al . Visual acuity, strabismus, and amblyopia in premature babies with and without retinopathy of prematurity.  Ann Ophthalmol. 1988;  20 256-258
  PubMedGoogle Scholar
• 114 STOP-ROP. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity, a randomized, controlled trial. I: primary outcomes.  Pediatrics. 2000;  105 295-310
  CrossrefPubMedGoogle Scholar
• 115 Steinkuller P G, Du L, Gilbert C. et al . Childhood blindness.  J Aapos. 1999;  3 26-32
  PubMedGoogle Scholar
• 116 Tasman W. Retinal detachment in retrolental fibroplasia (RLF).  Bibl Ophthalmol. 1969;  79 371-376
  PubMedGoogle Scholar
• 117 Tasman W. Late complications of retrolental fibroplasia.  Ophthalmology. 1979;  86 1724-1740
  PubMedGoogle Scholar
• 118 Terry T L. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each cristalline lens I. Preliminary report.  Am J Ophthalmol. 1942;  25 203-204
  PubMedGoogle Scholar
• 119 The Royal College of Ophthalmologists and the British Association of Perinatal Medicine . Retinopathy of prematurity: guidelines for screening and treatment. The report of a Joint Working Party of The Royal College of Ophthalmologists and the British Association of Perinatal Medicine.  Early Hum Dev. 1996;  46 239-258
  CrossrefPubMedGoogle Scholar
• 120 Trese M T, Droste P J. Long-term postoperative results of a consecutive series of stages 4 and 5 retinopathy of prematurity.  Ophthalmology. 1998;  105 992-997
  CrossrefPubMedGoogle Scholar
• 121 White J E, Repka M X. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: 3-year outcome.  J Pediatr Ophthalmol Strabismus. 1997;  34 83-87
  PubMedGoogle Scholar
• 122 Yamashita Y. Studies on retinopathy of prematurity. III. Cryocautery for retinopathy of prematurity.  Rinsho Ganka. 1972;  26 385-393
  PubMedGoogle Scholar
• 123 Yen K G, Hess D, Burke B. et al . Telephotoscreening to detect retinopathy of prematurity: preliminary study of the optimum time to employ digital fundus camera imaging to detect ROP.  J Aapos. 2002;  6 64-70
  PubMedGoogle Scholar
• 124 Zilis J D, deJuan E, Machemer R. Advanced retinopathy of prematurity. The anatomic and visual results of vitreous surgery.  Ophthalmology. 1990;  97 821-826
  PubMedGoogle Scholar

Dr. Claudia Jandeck

Universitätsaugenklinik, Charité - Universitätsmedizin Berlin

Campus Benjamin Franklin

Hindenburgdamm 30

12200 Berlin

Phone: +49-30-84 45 23 31

Fax: +49-30-84 45 44 50

Email: claudia.jandeck@charite.de